… patients diagnosed with glioblastoma. We also present the recent advances and perspectives
… as new therapeutic approaches such as cancer vaccination and personalized treatments. …

… In conclusion, advanced MRI techniques show huge promise in treatment response
assessment. The clinical readiness analysis highlights that most monitoring biomarkers require …

… data supporting their capacity to differentiate between glioma grade, assess response to
therapy and indicate the extent of patient immune responses. Additionally, the miR-21 …

… glioma treatment response assessment convened through a European framework. Current
evidence regarding the potential for monitoring biomarkers in adult high-grade glioma is …

… assessment of responses to treatment in gliomas. The RANO criteria, which involve the
radiology-based evaluation … 7-T CEST-MRI enables early response assessments 4 weeks ahead …

… In patients with malignant gliomas, RN is a severe local tissue reaction to radiotherapy.
Classical RN represents a variant of post-treatment effects, which is different from PsP in terms of …

… landscape of early interventions in newly diagnosed glioblastoma, based mostly on preclinical
and early phase clinical trial data. Our aim is to stimulate novel treatment approaches to …

… the diagnosis and therapy response assessment of brain tumours. They found four studies
that sought to assess … from treatment related changes, including a total of 161 glioma patients …

… signs and symptoms for use as clinical outcomes assessments in trials including patients
with malignant gliomas: … in trials including patients with malignant gliomas: Panel 1 Report. …

… Malignant gliomas are still extremely difficult to treat because complete surgical resection
is biologically not feasible due to the invasive nature of these diseases and the proximity of …